Melanoma cells show a heterogeneous range of sensitivity to ionizing radiation and are radiosensitized by inhibition of B-RAF with PLX-4032

Radiotherapy and Oncology

Volumn 98, Issue 3, 2011, Pages 394-399

  Sambade, Maria J ^a,b   Peters, Eldon C ^a,b   Thomas, Nancy E ^a,b   Kaufmann, William K ^a,b   Kimple, Randall J ^a,b   Shields, Janiel M ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

B RAF; Melanoma; PLX 4032; Radiosensitization

Indexed keywords

B RAF KINASE; PLX 4032;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL INVASION; CELL SURVIVAL; CLONOGENIC ASSAY; COLONY FORMATION; CONTROLLED STUDY; IONIZING RADIATION; MELANOMA CELL; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY; RADIOSENSITIZATION; SPHEROID CELL; SURVIVAL RATE;

BLOTTING, WESTERN; CELL LINE, TUMOR; FLOW CYTOMETRY; HUMANS; INDOLES; MELANOMA; PROTO-ONCOGENE PROTEINS B-RAF; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; SULFONAMIDES;

EID: 79952453763     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.12.017     Document Type: Article

References (43)

1. B.K. Edwards, E. Ward, and B.A. Kohler Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates Cancer 116 2010 544 573
2. S. Bhatia, S.S. Tykodi, and J.A. Thompson Treatment of metastatic melanoma: an overview Oncology (Williston Park) 23 2009 488 496
3. R. Mouawad, M. Sebert, and J. Michels Treatment for metastatic malignant melanoma: old drugs and new strategies Crit Rev Oncol Hematol 74 2010 27 39
4. B.A. Guadagnolo, and G.K. Zagars Adjuvant radiation therapy for high-risk nodal metastases from cutaneous melanoma Lancet Oncol 10 2009 409 416
5. G. Stevens, and M.J. McKay Dispelling the myths surrounding radiotherapy for treatment of cutaneous melanoma Lancet Oncol 7 2006 575 583 (Pubitemid 43923675)
6. L.L. Doss, and N. Memula The radioresponsiveness of melanoma Int J Radiat Oncol Biol Phys 8 1982 1131 1134 (Pubitemid 12053187)
7. E.K. Rofstad, and T. Brustad Broad-shouldered survival curves of a human melanoma xenograft. Implications for radiation therapy in the absence and presence of misonidazole Acta Radiol Oncol 20 1981 261 265 (Pubitemid 12247316)
8. D.T. Chang, R.J. Amdur, and C.G. Morris Adjuvant radiotherapy for cutaneous melanoma: comparing hypofractionation to conventional fractionation Int J Radiat Oncol Biol Phys 66 2006 1051 1055 (Pubitemid 44637160)
9. W.T. Sause, J.S. Cooper, and S. Rush Fraction size in external beam radiation therapy in the treatment of melanoma Int J Radiat Oncol Biol Phys 20 1991 429 432
10. B. Burmeister, M. Henderson, and J. Thompson Adjuvant radiotherapy improves regional (lymph node field) control in melanoma patients after lymphadenectomy: results of an intergroup randomized trial (TROG 02.01/ANZMTG 01.02) Int J Radiat Oncol Biol Phys 75 2009 S2 [abstract]
11. J.S. Cooper Radiation therapy of malignant melanoma Dermatol Clin 20 2002 713 716
12. A. Testori, P. Rutkowski, and J. Marsden Surgery and radiotherapy in the treatment of cutaneous melanoma Ann Oncol 20 2009 viz22 viz29
13. N. Seetharamu, P.A. Ott, and A.C. Pavlick Novel therapeutics for melanoma Expert Rev Anticancer Ther 9 2009 839 849
14. H. Davies, G.R. Bignell, and C. Cox Mutations of the BRAF gene in human cancer Nature 417 2002 949 954 (Pubitemid 34716871)
15. K. Omholt, A. Platz, and L. Kanter NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression Clin Cancer Res 9 2003 6483 6488 (Pubitemid 38031837)
16. J.M. Shields, N.E. Thomas, and M. Cregger Lack of extracellular signal-regulated kinase mitogen-activated protein kinase signaling shows a new type of melanoma Cancer Res 67 2007 1502 1512 (Pubitemid 46389241)
17. J. Greshock, K. Nathanson, and A. Medina Distinct patterns of DNA copy number alterations associate with BRAF mutations in melanomas and melanoma-derived cell lines Genes Chromosomes Cancer 48 2009 419 428
18. M.J. Sambade, J.T. Camp, and R.J. Kimple Mechanism of lapatinib-mediated radiosensitization of breast cancer cells is primarily by inhibition of the Raf > MEK > ERK mitogen-activated protein kinase cascade and radiosensitization of lapatinib-resistant cells restored by direct inhibition of MEK Radiother Oncol 93 2009 639 644
19. P.J. Roberts, and C.J. Der Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer Oncogene 26 2007 3291 3310 (Pubitemid 46763022)
20. K. Rajalingam, R. Schreck, and U.R. Rapp Ras oncogenes and their downstream targets Biochim Biophys Acta 1773 2007 1177 1195 (Pubitemid 47125979)
21. T.M. Grana, E.V. Rusyn, and H. Zhou Ras mediates radioresistance through both phosphatidylinositol 3-kinase-dependent and Raf-dependent but mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-independent signaling pathways Cancer Res 62 2002 4142 4150 (Pubitemid 34791086)
22. V. Brower BRAF inhibitors: research accelerates in wake of positive findings J Natl Cancer Inst 102 2010 214 215
23. K.T. Flaherty, I. Puzanov, and K.B. Kim Inhibition of mutated, activated BRAF in metastatic melanoma N Engl J Med 363 2010 809 819
24. J. Tsai, J.T. Lee, and W. Wang Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity Proc Natl Acad Sci USA 105 2008 3041 3046 (Pubitemid 351723664)
25. S.A. Amundson, K.T. Do, and L.C. Vinikoor Integrating global gene expression and radiation survival parameters across the 60 cell lines of the National Cancer Institute Anticancer Drug Screen Cancer Res 68 2008 415 424 (Pubitemid 351380067)
26. S.J. Heidorn, C. Milagre, and S. Whittaker Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF Cell 140 2010 209 221
27. P.I. Poulikakos, C. Zhang, and G. Bollag RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF Nature 464 2010 427 430
28. G. Hatzivassiliou, K. Song, and I. Yen RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth Nature 363 2010 431 435
29. R. Halaban, W. Zhang, and A. Bacchiocchi PLX4032, a selective BRAF (V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cells Pigment Cell Melanoma Res 23 2010 190 200
30. U. Doehn, C. Hauge, and S.R. Frank RSK is a principal effector of the RAS-ERK pathway for eliciting a coordinate promotile/invasive gene program and phenotype in epithelial cells Mol Cell 35 2009 511 522
31. J.T. Huntington, J.M. Shields, and C.J. Der Overexpression of collagenase 1 (MMP-1) is mediated by the ERK pathway in invasive melanoma cells: role of BRAF mutation and fibroblast growth factor signaling J Biol Chem 279 2004 33168 33176 (Pubitemid 39062961)
32. E.K. Rofstad Radiation biology of malignant melanoma Acta Radiol Oncol 25 1986 1 10 (Pubitemid 16111189)
33. M.J. McKay, and R.F. Kefford The spectrum of in vitro radiosensitivity in four human melanoma cell lines is not accounted for by differential induction or rejoining of DNA double strand breaks Int J Radiat Oncol Biol Phys 31 1995 345 352
34. S.C. Barranco, M.M. Romsdahl, and R.M. Humphrey The radiation response of human malignant melanoma cells grown in vitro Cancer Res 31 1971 830 833
35. R. Manon, A. O'Neill, and J. Knisely Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: an Eastern Cooperative Oncology Group study (E 6397) J Clin Oncol 23 2005 8870 8876 (Pubitemid 46211534)
36. C. Gaudy-Marqueste, J.M. Regis, and X. Muracciole Gamma-knife radiosurgery in the management of melanoma patients with brain metastases: a series of 106 patients without whole-brain radiotherapy Int J Radiat Oncol Biol Phys 65 2006 809 816 (Pubitemid 43795850)
37. U. Selek, E.L. Chang, and S.J. Hassenbusch 3rd Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases Int J Radiat Oncol Biol Phys 59 2004 1097 1106 (Pubitemid 38834303)
38. D. Mathieu, D. Kondziolka, and P.B. Cooper Gamma knife radiosurgery in the management of malignant melanoma brain metastases Neurosurgery 60 2007 471 481 [discussion 481-72] (Pubitemid 46339184)
39. T.M. Grana, C.I. Sartor, and A.D. Cox Epidermal growth factor receptor autocrine signaling in RIE-1 cells transformed by the Ras oncogene enhances radiation resistance Cancer Res 63 2003 7807 7814 (Pubitemid 37466713)
40. K.F. Pirollo, Z. Hao, and A. Rait Evidence supporting a signal transduction pathway leading to the radiation-resistant phenotype in human tumor cells Biochem Biophys Res Commun 230 1997 196 201 (Pubitemid 27210272)
41. C.I. Sartor Mechanisms of disease: radiosensitization by epidermal growth factor receptor inhibitors Nat Clin Pract Oncol 1 2004 80 87 (Pubitemid 40823747)
42. J.A. Bonner, P.M. Harari, and J. Giralt Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med 354 2006 567 578 (Pubitemid 43209104)
43. G.V. Long, R.F. Kefford, and P.J.A. Carr GSK2118436 Phase 1/2 study of a selective inhibitor of V600 mutant Braf kinase: evidence of activity in melanoma brain metastases Ann Oncol 1 2010 80 82 [LBA27 [abstract]]